BKG VET PHARMA ApS: Financial statements 2015
CVR: 34044341
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
BKG VET PHARMA ApS (CVR 34044341) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -124,919 and a net result of DKK -628,792 compared with DKK -41,653 the year before. Equity in the 2015 report amounted to DKK 6,977,876. The solvency ratio was 80.3%.
- Gross Profit
- DKK -124,919
- Profit/Loss
- DKK -628,792
- Equity
- DKK 6,977,876
- Total Assets
- DKK 8,691,765
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -125 t. | -629 t. | 7 mio. | - |
| 2014 | - | -120 t. | -42 t. | 7.6 mio. | - |
| 2013 | - | -89 t. | 93 t. | 7.6 mio. | - |
Official annual report
How creditworthy is BKG VET PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
BKG VET PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -120,090, and the net result was DKK -41,653.
As of June 25, 2015, Claus Fertin has joined the board of directors of BKG VET PHARMA ApS.
As of June 25, 2015, Jan Mousing has left the board of directors of BKG VET PHARMA ApS.
About BKG VET PHARMA ApS
BKG VET PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2011. The company has been dissolved on 31 March 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2017). In 2018, the company reported a gross profit of DKK -36,050 and a net result of DKK -94,791 compared with DKK -329,327 the year before. Equity in the 2018 report amounted to DKK 225,768.